Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 08, 2009 19:33 ET | Source: Talon Therapeutics, Inc.

Hana Biosciences Receives NASDAQ Delisting Notification

SOUTH SAN FRANCISCO, Calif., Sept. 8, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB) today announced that the Company received a letter from the Staff of The NASDAQ Stock Market indicating...
August 14, 2009 17:45 ET | Source: Talon Therapeutics, Inc.

Hana Biosciences Announces Second Quarter 2009 Results

SOUTH SAN FRANCISCO, Calif., Aug. 14, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced...
August 12, 2009 07:05 ET | Source: Talon Therapeutics, Inc.

Hana Biosciences Reaches Patient Enrollment Target for Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia

56th Subject Enrolled and Dosed Data Presentation Targeted for 2009 ASH Annual Meeting NDA Submission Targeted for First Half of 2010 SOUTH SAN...
June 02, 2009 06:30 ET | Source: Talon Therapeutics, Inc.

Hana Biosciences Presents Updated Marqibo Data At the American Society of Clinical Oncology Annual Meeting

* 30% CR/CRi Rate in First 33 rALLy Subjects * rALLy Study Expected to Reach Target Enrollment by Mid-Year * Encouraging Survival in Metastatic Uveal Melanoma Trial SOUTH SAN FRANCISCO,...
May 15, 2009 07:05 ET | Source: Talon Therapeutics, Inc.

Hana Biosciences Announces First Quarter 2009 Results

SOUTH SAN FRANCISCO, Calif., May 15, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced...
April 09, 2009 17:53 ET | Source: Talon Therapeutics, Inc.

Hana Biosciences Receives Going Concern Qualification

SOUTH SAN FRANCISCO, Calif., April 9, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences, Inc., (Nasdaq:HNAB), a biopharmaceutical company focused on developing and commercializing new, differentiated cancer...
March 31, 2009 16:05 ET | Source: Talon Therapeutics, Inc.

Hana Biosciences Reports Fourth Quarter and Full Year 2008 Results

SOUTH SAN FRANCISCO, Calif., March 31, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences Inc., (Nasdaq:HNAB), a biopharmaceutical company focused on developing and commercializing new, differentiated cancer...
March 18, 2009 07:30 ET | Source: Talon Therapeutics, Inc.

Hana Biosciences to Report Fourth Quarter and Full Year 2008 Financial Results On March 31, 2009

SOUTH SAN FRANCISCO, Calif., March 18, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB) will announce its fourth quarter and full year 2008 results on Tuesday, March 31, 2009, after the close...
March 11, 2009 16:30 ET | Source: Talon Therapeutics, Inc.

Hana Biosciences Receives NASDAQ Notice; Will Request Hearing

SOUTH SAN FRANCISCO, Calif., March 11, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB) today announced that the Company received a letter on March 5, 2009 from the Listing Qualifications Staff...
February 02, 2009 07:30 ET | Source: Talon Therapeutics, Inc.

Hana Biosciences to Present at the 11th Annual BIO CEO & Investor Conference On February 10, 2009

SOUTH SAN FRANCISCO, Calif., Feb. 2, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...